IQWiG Sees Value In Olysio, As Janssen Looks To Link It With Sovaldi
This article was originally published in The Pink Sheet Daily
Executive Summary
German reimbursement assessment gives Janssen’s HCV protease inhibitor a strong but narrow recommendation.